ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005

Budget Presents “Themes,” Not Individual NIH Institutes.

April 13, 2001

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975